Sporadic Fatal Insomnia in an Adolescent abstract occurrence of sporadic prion disease among adolescents is ex

tremely rare. A prion disease was confirmed in an adolescent with disease onset at 13 years of age. Genetic, neuropathologic, and biochemical analyses of the patient’s autopsy brain tissue were consistent with sporadic fatal insomnia, a type of sporadic prion disease. There was no evidence of an environmental source of infection, and this patient represents the youngest documented case of sporadic prion disease. Although rare, a prion disease diagnosis should not be discounted in adolescents exhibiting neurologic signs. Brain tissue testing is necessary for disease confirmation and is particularly beneficial in cases with an unusual clinical presentation. Pediatrics 2014;133:e1–e5

[1]  A. Bizzi,et al.  Sporadic human prion diseases: molecular insights and diagnosis , 2012, The Lancet Neurology.

[2]  Adriano Aguzzi,et al.  Molecular mechanisms of prion pathogenesis. , 2008, Annual review of pathology.

[3]  M. Doran,et al.  Sporadic Creutzfeldt–Jakob disease in two adolescents , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[4]  R. Castellani,et al.  Classification of sporadic Creutzfeldt-Jakob disease revisited. , 2006, Brain : a journal of neurology.

[5]  D. Perani,et al.  Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies. , 2006, Brain : a journal of neurology.

[6]  Shu G. Chen,et al.  Sporadic and familial CJD: classification and characterisation. , 2003, British medical bulletin.

[7]  Pietro Cortelli,et al.  Familial and sporadic fatal insomnia , 2003, The Lancet Neurology.

[8]  S. Chin,et al.  A subtype of sporadic prion disease mimicking fatal familial insomnia , 1999, Neurology.

[9]  F. Cohen,et al.  Eight prion strains have PrPSc molecules with different conformations , 1998, Nature Medicine.

[10]  J Q Trojanowski,et al.  Molecular basis of phenotypic variability in sporadc creudeldt‐jakob disease , 1996, Annals of neurology.

[11]  R. Castellani,et al.  Early pathologic and biochemical changes in Creutzfeldt-Jakob disease , 1996, Neurology.

[12]  A. Hofman,et al.  A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.

[13]  R. Castellani,et al.  Regional distribution of protease‐resistant prion protein in fatal familial insomnia , 1995, Annals of neurology.

[14]  E. Sforza,et al.  Sleep-wake cycle abnormalities in fatal familial insomnia. Evidence of the role of the thalamus in sleep regulation. , 1995, Electroencephalography and clinical neurophysiology.

[15]  B. Ghetti,et al.  Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Stephen J. DeArmond,et al.  Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication , 1990, Cell.

[17]  S. Prusiner,et al.  Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells , 1990, The Journal of cell biology.

[18]  R. Kalb,et al.  Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report. , 1988, Journal of neurosurgery.

[19]  J. Parisi,et al.  Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. , 1985, The New England journal of medicine.

[20]  B. Berg,et al.  Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone. , 1985, The New England journal of medicine.

[21]  E. Belay.  Transmissible spongiform encephalopathies in humans. , 1999, Annual review of microbiology.